Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
Author:
Affiliation:
1. Division of Endocrinology, Diabetes and Metabolism; University of Florida; Gainesville Florida
2. Virginia Commonwealth University Medical Center; Richmond Virginia
3. Eli Lilly and Company, Lilly Corporate Center; Indianapolis Indiana
Funder
Eli Lilly and Company
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12973/fullpdf
Reference20 articles.
1. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE;Doycheva;Aliment Pharmacol Ther,2016
2. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994;Lazo;Am J Epidemiol,2013
3. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study;Williams;Gastroenterology,2011
4. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002
5. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms;Saponaro;Curr Diab Rep,2015
Cited by 149 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17
2. Metabolic dysfunction-associated steatotic liver disease and diabetes: the cross-talk between hepatologist and diabetologist;Expert Review of Gastroenterology & Hepatology;2024-08-02
3. “Adjusting internal organs and dredging channelon” electroacupuncture glycolipid metabolism disorders in NAFLD mice by mediating the AMPK/ACC signaling pathway;Diabetology & Metabolic Syndrome;2024-07-25
4. Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes;Diabetes, Obesity and Metabolism;2024-07-10
5. Metabolic dysfunction‐associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes;Diabetes, Obesity and Metabolism;2024-06-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3